Research suggests that turmeric, primarily through its active compound curcumin, shows meaningful promise for a range of digestive health applications, with the most consistent evidence coming from studies on inflammatory bowel conditions and functional digestive complaints. Multiple randomized controlled trials and a 2022 meta-analysis indicate that curcumin supplementation improved clinical outcomes in ulcerative colitis and Crohn's disease, and one 2023 RCT found curcumin comparable to omeprazole for functional dyspepsia, while a separate RCT noted secondary benefits including reduced flatulence and ulcer-related symptoms. The body of evidence spans RCTs, meta-analyses, and numerous reviews dating back to 2007, and the overall direction is broadly supportive, though a 2023 scoping review and a 2022 review of ulcerative colitis treatments both characterize the results as mixed depending on the specific condition and study design. A notable complexity in interpreting this research is curcumin's poor systemic absorption, which some researchers propose may actually be less relevant than previously assumed, since curcumin may exert many of its effects directly within the gastrointestinal tract through interactions with gut bacteria rather than through the bloodstream — a hypothesis that remains an active area of investigation.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, d... | RCT | 2023 | Supports | 95 |
| Advancing Gastrointestinal Health: Curcumin's Efficacy and Nanopreparations. | Review | 2024 | Supports | 93 |
| Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A R... | RCT | 2024 | Supports | 92 |
| Therapeutic roles of curcumin: lessons learned from clinical trials. | Review | 2013 | Supports | 90 |
| Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate ... | RCT | 2024 | Supports | 88 |
| Turmeric and Curcumin: From Traditional to Modern Medicine. | Other | 2021 | Supports | 85 |
| Interaction between Gut Microbiota and Curcumin: A New Key of Understanding f... | Review | 2020 | Supports | 85 |
| Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials. | Review | 2023 | Mixed | 82 |
| Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune... | Meta-analysis | 2022 | Supports | 80 |
| Curcumin: the Indian solid gold. | Review | 2007 | Supports | 80 |
| Nutritional regulators of intestinal inflammation. | Review | 2019 | Supports | 75 |
| Curcumin, an active component of turmeric: biological activities, nutritional... | Review | 2025 | Supports | 72 |
| Ulcerative Colitis: Rapid Evidence Review. | Review | 2022 | Mixed | 65 |
| Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a r... | RCT | 2019 | Supports | 60 |